Levetiracetam Treatment of Tardive Dyskinesia

NCT00291213 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Tardive Dyskinesia

Interventions

DRUG: levetiracetam
DRUG: placebo

Sponsor

Yale University

Collaborators

[object Object]